Virtu Financial LLC Processa Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

  • $1.82 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$0.24 - $0.53 $3,613 - $7,979
-15,056 Reduced 56.45%
11,617 $3,000
Q2 2023

Jul 27, 2023
BUY
$0.44 - $0.73 $6,038 - $10,018
13,724 Added 105.99%
26,673 $13,000
Q1 2023

May 01, 2023
BUY
$0.41 - $1.3 $5,309 - $16,833
12,949 New
12,949 $7,000

About Processa Pharmaceuticals, Inc.

PCSA Quotes by TradingView
  • Ticker PCSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,856,200
  • Market Cap $14.6M
  • Description
  • Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...
More about PCSA
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email